Cantitate/Preț
Produs

Comparative Effectiveness of Medical Treatments

Editat de Peter Villa, Sophia Brun
en Limba Engleză Paperback – 18 aug 2009
This book explores the comparative effectiveness of medical treatments as applied in the health care sector. An analysis of comparative effectiveness is simply a comparison of the impact of different options that are available for treating a given medical condition for a particular set of patients. These studies may compare both similar treatments, such as competing drugs, or they may analyse very different approaches, such as surgery and drug therapy. The analysis may focus only on the relative medical benefits and risks of each option, or it may go on to weigh both the costs and the benefits of those options. In some cases, a given treatment may be found more effective for all types of patients, but more commonly a key issue is determining which specific types would benefit most from it. Although some information about the effectiveness of new drugs, medical devices, or procedures is often available, rigorous comparisons of different treatment options are less common. Thus, this book compares and discusses which treatments work best for which patients and whether the added benefits of more-effective but more-expensive services are sufficient to warrant their added costs.
Citește tot Restrânge

Preț: 29848 lei

Preț vechi: 40702 lei
-27% Nou

Puncte Express: 448

Preț estimativ în valută:
5712 5913$ 4828£

Carte disponibilă

Livrare economică 13-27 februarie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781607411093
ISBN-10: 1607411091
Pagini: 96
Ilustrații: tables & charts
Dimensiuni: 154 x 225 x 8 mm
Greutate: 0.2 kg
Editura: Nova Science Publishers Inc

Cuprins

Preface; Research on the Comparative Effectiveness of Medical Treatments: Options for an Expanded Federal Role before the Subcommittee on Health Committee on Ways & Means; Producing Comparative-Effectiveness Information before the Subcommittee on Health, Committee on Ways & Means, U.S. House of Representatives; Testimony of Steven M. Teutsch, Outcomes Research, External Medical & Scientific Affairs, Merck & Co., Inc. Before the House Ways & Means Health Subcommittee, 12 June 2007 Concerning Effectiveness; House Committee on Ways & Means, Statement of Carolyn M. Clancy, Agency for Healthcare Research & Quality, Rockville, Maryland, Testimony before the Subcommittee on Health of the House Committee on Ways & Means, 12 June 2007; House Committee on Ways & Means, Statement of David Dale, American College of Physicians, Testimony before the Subcommittee on Health of the House Committee on Ways & Means, 12 June 2007; House Committee on Ways & Means, Statement of Gail Shearer, Health Policy Analysis, Consumers Union, Testimony before the Subcommittee on Health of the House Committee on Ways & Means, 12 June 2007; House Committee on Ways & Means, Statement of Susan Hearn, Environment Health & Safety, Dow Chemical Company, Midland, Michigan, Testimony Before the Subcommittee on Health of the House Committee on Ways & Means, 12 June 2007; House Committee on Ways & Means, Statement of the Honourable Thomas Allen, A Representative in Congress from the State of Maine, Testimony before the Subcommittee on Health of the House Committee on Ways & Means, 12 June 2007; Background to Hearing on Strategies to Increase Information on Comparative Clinical Effectiveness from House Ways & Means Health Subcommittee Chairman Pete Stark; Index.